IN BRIEF: Voyager Life posts maiden 17-month loss, bets on CBD market

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Voyager Life PLC - Perth, Scotland-based supplier of cannabidiol and hemp seed oil products - Posts maiden loss for 17 month period after its initial public offering in summer 2021. Pretax loss for the period from November 2020 to March 31, 2022 stands at £801,000. Reports revenue of £178,000. Administrative expenses are £797,000. Says IPO associated costs are £106,000.

‘The directors recognise that, although growing strongly, the cannabidiol market in the UK and overseas remains highly competitive and, furthermore, that the competition is not always on a level playing field with several companies continuing to sell what the directors believe are sub-standard products and make unsubstantiated health claims. The confusion caused by the delayed publication of the Food Standards Agency's list of CBD companies that it validated under the novel foods regulations has created further challenges,’ says Chief Executive Officer Nick Tulloch. He adds that directors believe the cannabidiol supplier will thrive in the long term.

Voyager Life had its IPO on the Aquis Stock Exchange in June 2021.

Current stock price: 13.5 pence

Copyright 2022 Alliance News Limited. All Rights Reserved.